Skip to main content
Visualsonic logo
Account
  • Login
Back
  • Products
    • Products
    • Imaging Systems
      • Vevo F2xc
      • Vevo LAZR-X20
      • Vevo F2xc LT
    • Transducers
      • Browse All Transducers
      • Vevo Optical Fibers and Jackets
    • Vevo LAB Analysis Suite
      • About Vevo LAB
      • Vevo CQ
      • Vevo Strain 2.0
      • Vevo Multiplexer
      • LV Analysis
      • Auto LV
      • Update your Vevo LAB Software
    • Imaging Modes Software
      • High-frequency Ultrasound Imaging
        • All Imaging Modes
        • 4D-Mode
        • B-Mode
        • 3D-Mode
        • M-Mode
        • Anatomical M-Mode
        • Nonlinear Contrast Mode
        • Power Doppler Mode
        • Pulsed-Wave Doppler Mode
        • Color Doppler Mode
        • Tissue Doppler Imaging
        • Digital RF-Mode
        • ECG and Respiration Gating
        • EKV
        • Shear Wave Elastography
        • Ultrafast Doppler
        • Vector Flow Imaging
      • Photoacoustic Imaging
        • Single Wavelength
        • Oxy-hemo
        • Spectro
        • Multi-wavelength
        • PA EKV
      • Acoustics & Engineering
        • VADA
    • Accessories
      • Vevo Imaging Station
      • Vevo Whole Body Imaging
      • Vevo Animal Monitoring System
      • Vevo Infusion Pump
      • Vevo PHANTOM
      • Vevo BRAIN
    • Contrast Agents
      • Photoacoustic Contrast Agents
        • About PA Contrast Agents
        • Angiostamp™800
      • Ultrasound Contrast Agents
        • Vevo MicroMarker
  • Applications
    • Applications
    • Preclinical
      • Cardiology
      • Oncology
      • Neurobiology
      • Biomarker/Molecular Imaging
      • Vascular Biology
      • Developmental
      • Image-guided Injection
      • Theranostics
      • Ischemia/Reperfusion
      • Drug Discovery and Development
      • Colorectal
      • Urogenital
      • Kidney
      • Liver
      • Fibrosis
      • Pulmonary
      • Pancreas
      • MSK
  • Resources
    • Resources
    • FAQ
    • Education
      • Learning Hub: Online Tutorials
      • Tips and Tricks
      • JoVE Videos
      • Request Training
      • Vevo University
      • In vivo Imaging
    • News and Stories
      • Shared Stories
      • Vevo Blog
      • Research Spotlight
      • Case Studies
    • Grants & Fundings
      • Vevo International Student Awards
      • Grant Support
      • List of Grants & Funding
      • Funded Projects
    • Publications Library
    • Image Gallery
    • Recorded Webinars
    • On Demand Videos
  • Events
    • Events
    • Conferences and Society Meetings
    • Upcoming Webinars
    • Upcoming Workshops
  • Support
    • Support
    • Scientific Support
    • Technical Support
    • Vevo Service Plans
    • Request Training
    • FAQ
  • Our Company
    • Our Company
    • About Us
    • News
    • Our Technology
      • Our Technology
      • Ultra High-Frequency Ultrasound
      • Photoacoustics (PA)
      • Imaging Modes
    • Scientific Advisory Board
    • Patents
  • Contact
    • Contact
    • Contact Us
    • Our Global Offices
    • Maps and Directions
    • Distributors
  • Careers
    • Careers
    • Open Positions at VisualSonics
    • External Job Postings

Search

Publication
Four Surgical Modifications to the Classic Elastase Perfusion Aneurysm Model Enable Haemodynamic Alterations and Extended Elastase Perfusion
OBJECTIVE/BACKGROUND: Abdominal aortic aneurysm (AAA) is an individual and socioeconomic burden in today's ageing society. Treatment relies on surgical exclusion of the dilated aorta by open or endovascular repair. For research purposes, animal models are …
Read more
Publication
Palmitic acid, but not high-glucose, induced myocardial apoptosis is alleviated by N‑acetylcysteine due to attenuated mitochondrial-derived ROS accumulation-induced endoplasmic reticulum stress
Pharmacological inhibition of reactive oxygen species (ROS) is a potential strategy to prevent diabetes-induced cardiac dysfunction. This study was designed to investigate precise effects of antioxidant N‑acetylcysteine (NAC) in alleviating diabetic …
Read more
Publication
A Murine Frailty index based on Clinical and Laboratory Measurements: Links between Frailty and Pro-inflammatory Cytokines differ in a Sex-specific Manner
A frailty index based on clinical deficit accumulation (FI-Clinical) quantifies frailty in aging mice. We aimed to develop a laboratory test-based murine FI tool (FI-Lab) and to investigate the effects of age and sex on FI-Lab scores, FI-Clinical scores …
Read more
Publication
Maternal treatment with a placental-targeted antioxidant ( MitoQ ) impacts o ff spring cardiovascular function in a rat model of prenatal hypoxia
Intrauterine growth restriction, a common consequence of prenatal hypoxia, is a leading cause of fetal morbidity and mortality with a significant impact on population health. Hypoxia may increase placental oxidative stress and lead to an abnormal release …
Read more
Publication
The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction
Introduction: Rivaroxaban selectively inhibits factor Xa (FXa), which plays a central role in blood coagulation. In addition, FXa activates protease-activated receptor-2 (PAR-2). We have shown that PAR-2-/- mice exhibit less cardiac dysfunction after …
Read more
Publication
Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats
Background: The western diet high in fat and fructose may cause metabolic disorders and cardiovascular diseases. Objective: To evaluate whether long-term daily vitamin D3 supplementation prevents hepatic steatosis and cardiovascular abnormalities and …
Read more
Publication
Humanin Analogue (HNG) Enhances the Protective Effect of Dexrazoxane against Doxorubicin-induced Cardiotoxicity
The chemotherapeutic effect of Doxorubicin (Dox) is limited by cumulative dose-dependent cardiotoxicity in cancer survivors. Dexrazoxane (DRZ) is approved to prevent Dox-induced cardiotoxicity. Humanin and its synthetic analog HNG have cytoprotective …
Read more
Publication
PIMT/NCOA6IP Deletion in the Mouse Heart Causes Delayed Cardiomyopathy Attributable to Perturbation in Energy Metabolism
PIMT/NCOA6IP, a transcriptional coactivator PRIP/NCOA6 binding protein, enhances nuclear receptor transcriptional activity. Germline disruption of PIMT results in early embryonic lethality due to impairment of development around blastocyst and uterine …
Read more
Publication
Cardioprotection Induced by Activation of GPER in Ovariectomized Rats With Pulmonary Hypertension
Abstract Pulmonary hypertension (PH) is a disease of women (female-to-male ratio 4:1), and is associated with cardiac and skeletal muscle dysfunction. Herein, the activation of a new estrogen receptor (GPER) by the agonist G1 was evaluated in …
Read more
Publication
Tumor inhibitory effects of intravesical Ganoderma lucidum instillation in the syngeneic orthotopic MB49/C57 bladder cancer mice model
Ethnopharmacological relevance: Ganoderma lucidum (GL) has been traditionally used in oriental medicine as superior health tonic, and there are numerous scientific evidences of its antitumorigenic activities. Aim of the study: To evaluate the intravesical …
Read more

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 335
  • Page 336
  • Page 337
  • Page 338
  • Current page 339
  • Page 340
  • Page 341
  • Page 342
  • Page 343
  • …
  • Next page ››
  • Last page Last »
  • Warranty and Service
  • Product Retirement
  • Security
  • Accessibility
  • Modern Slavery Act
  • Privacy
  • Terms of Service

Contact

Call us at: 1.866.416.4636 | Europe: +31 20 808 2913 | Subscribe To Our Mailing List


VisualSonics, the VisualSonics logo, Vevo, Vevo MicroMarker and EKV are registered and unregistered trademarks of FUJIFILM Sonosite, Inc. in various jurisdictions. FUJIFILM is a registered trademark of FUJIFILM Corporation in various jurisdictions.

Copyright © 2026 FUJIFILM VisualSonics, Inc. All rights reserved. FUJIFILM VisualSonics, Inc is a subsidiary of FUJIFILM Sonosite, Inc.